Renal Infiltration of Immune Cells Mediates Hypertension
免疫细胞的肾浸润介导高血压
基本信息
- 批准号:7389280
- 负责人:
- 金额:$ 32.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAngiotensin IIAngiotensin II ReceptorAttenuatedBlood PressureCellsConstriction procedureDahl Hypertensive RatsDataDevelopmentDietDiseaseDisease modelDiuresisElevationEventExperimental GeneticsExperimental ModelsExposure toFree RadicalsFunctional disorderGenerationsGeneticHepatolenticular DegenerationHypertensionImmuneImmune systemImmunosuppressive AgentsInfiltrationInjuryIntakeKidneyKidney DiseasesLeadMaintenanceMediatingMediator of activation proteinModelingNatriuresisNumbersOrganPathogenesisPharmaceutical PreparationsPhaseProtocols documentationPublishingRattusRecoveryRenal HypertensionRenal TissueRenal functionReperfusion InjuryRoleSeveritiesSodiumSodium ChlorideSymptomsTestingTissuesTubular formationWaterdayfeedinghemodynamicsinterstitialkidney medullanovelpressurerenal ischemiaresearch studysalt sensitive
项目摘要
Project 2 will examine the role of infiltrating immune cells in the renal medulla in the pathogenesis of
salt-sensitive hypertension and renal injury. Preliminary and published data indicate that salt-sensitive
hypertension in both a genetic and an experimental rat model of disease is associated with extensive renal
injury, infiltration of immune cells into the kidney, and increased intrarenal angiotensin II (ANGII) levels.
Interestingly, pharmacological blockade of the immune system or of ANGII receptors attenuates the
development of hypertension and kidney damage in these disease models. Furthermore, administration of
immunosuppressive drugs directly into the renal medullary interstitial space decreases the severity of
hypertension, indicating that immune cell infiltration in the renal medulla is important in the pathophysiology of
salt-sensitive hypertension. Using these novel data as a rationale and a unique integrative experimental
approach, we will test the hypothesis that the infiltration of immune cells into the renal medulla following an
initial increase in arterial blood pressure after exposure to a high salt diet (4% NaCI) mediates the further
development of hypertension and kidney disease in Dahl Salt-Sensitive (SS) rats and in the salt-sensitive
hypertension that occurs following apparent recovery from renal ischemia-reperfusion injury in normal rats. We
further propose that the immune cells act by releasing ANGII which serves to increase the severity of
hypertension and renal damage. This novel hypothesis will be addressed in three Specific Aims. Aim 1 will
determine the importance of immune cell infiltration into the renal medullary interstitial space in the secondary
phase of genetic and experimental forms of salt-sensitive hypertension. Aim 2 will determine the ability of
infiltrating immune cells to synthesize and release ANGII into the kidney in experimental and genetic forms of
salt-sensitive hypertension. Aim 3 will determine the role of infiltrating immune cells in the kidney on renal
hemodynamics and the renal handling of sodium and water in experimental and genetic forms of salt-sensitive
hypertension.
项目2将研究肾髓质中的免疫细胞在肾炎发病机制中的作用。
盐敏感型高血压和肾脏损伤。初步和已公布的数据表明,对盐敏感
遗传性和实验性大鼠高血压均与肾脏广泛相关
损伤,免疫细胞渗入肾脏,肾内血管紧张素II(AngII)水平增加。
有趣的是,免疫系统或血管紧张素Ⅱ受体的药理阻断会减弱
在这些疾病模型中,高血压和肾脏损害的发展。此外,管理
直接进入肾髓质间隙的免疫抑制药物可降低肾小球硬化的严重程度。
提示肾髓质内免疫细胞的浸润在高血压的病理生理过程中起重要作用。
盐敏性高血压。利用这些新颖的数据作为理论基础和独特的综合实验
方法,我们将检验这样一种假设,即免疫细胞在肾髓质中的渗透
暴露于高盐饮食(4%NaCI)后动脉血压的初始升高介导了进一步的
Dahl盐敏感型(SS)大鼠和盐敏感型大鼠高血压和肾脏疾病的发展
正常大鼠肾缺血再灌注损伤明显恢复后发生的高血压。我们
进一步提出,免疫细胞通过释放血管紧张素转换酶来起作用,这有助于增加高血压的严重性
高血压和肾脏损伤。这一新的假设将在三个具体目标中得到解决。目标1将
确定免疫细胞在继发性肾间质病变中的重要性
盐敏感型高血压的遗传期和实验期。目标2将决定
以实验性和遗传性肾炎的形式渗透免疫细胞合成和释放血管紧张素转换酶Ⅱ到肾脏
盐敏性高血压。目标3将确定肾脏中浸润性免疫细胞在肾脏中的作用
实验性和遗传性盐敏感型患者的血流动力学和肾脏对钠和水的处理
高血压。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David L. Mattson其他文献
EGF Deficiency in the Renal Cortex Contributes to Salt-Sensitive Hypertension via Upregulation of ENaC Activity
- DOI:
10.1016/j.bpj.2011.11.3543 - 发表时间:
2012-01-31 - 期刊:
- 影响因子:
- 作者:
Tengis S. Pavlov;Vladislav Levchenko;Paul M. O’Connor;Andrey Sorokin;David L. Mattson;Julian H. Lombard;Allen W. Cowley;Alexander Staruschenko - 通讯作者:
Alexander Staruschenko
T Cell Immunometabolism and Redox Signaling in Hypertension
- DOI:
10.1007/s11906-021-01162-5 - 发表时间:
2021-12-01 - 期刊:
- 影响因子:5.100
- 作者:
David L. Mattson;Justine M. Abais-Battad - 通讯作者:
Justine M. Abais-Battad
Functional Genomics
- DOI:
10.1007/978-94-010-0448-0 - 发表时间:
2002 - 期刊:
- 影响因子:0
- 作者:
David L. Mattson - 通讯作者:
David L. Mattson
From GWAS to functional genomics-based precision medicine
从全基因组关联研究到基于功能基因组学的精准医学
- DOI:
10.1038/nrneph.2017.21 - 发表时间:
2017-03-06 - 期刊:
- 影响因子:39.800
- 作者:
David L. Mattson;Mingyu Liang - 通讯作者:
Mingyu Liang
Immune mechanisms of salt-sensitive hypertension and renal end-organ damage
盐敏感性高血压及肾终末器官损害的免疫机制
- DOI:
10.1038/s41581-019-0121-z - 发表时间:
2019-02-25 - 期刊:
- 影响因子:39.800
- 作者:
David L. Mattson - 通讯作者:
David L. Mattson
David L. Mattson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David L. Mattson', 18)}}的其他基金
Gut Metabolites, T cells, and Salt-Sensitive Hypertension
肠道代谢物、T 细胞和盐敏感性高血压
- 批准号:
10568068 - 财政年份:2023
- 资助金额:
$ 32.02万 - 项目类别:
Role of CD247 in Salt-Sensitive Hypertension and Renal Disease
CD247 在盐敏感性高血压和肾脏疾病中的作用
- 批准号:
8508937 - 财政年份:2012
- 资助金额:
$ 32.02万 - 项目类别:
Role of CD247 in Salt-Sensitive Hypertension and Renal Disease
CD247 在盐敏感性高血压和肾脏疾病中的作用
- 批准号:
8396503 - 财政年份:2012
- 资助金额:
$ 32.02万 - 项目类别:
Role of CD247 in Salt-Sensitive Hypertension and Renal Disease
CD247 在盐敏感性高血压和肾脏疾病中的作用
- 批准号:
8730147 - 财政年份:2012
- 资助金额:
$ 32.02万 - 项目类别:
Renal Infiltration of Immune Cells Mediates Hypertension
免疫细胞的肾浸润介导高血压
- 批准号:
8230994 - 财政年份:2011
- 资助金额:
$ 32.02万 - 项目类别:
Arginine Uptake Mechanisms Regulate Nitric Oxide in the Renal Vasculature
精氨酸摄取机制调节肾脉管系统中的一氧化氮
- 批准号:
7502047 - 财政年份:2003
- 资助金额:
$ 32.02万 - 项目类别:
Arginine Uptake Mechanisms Regulate Nitric Oxide in the Renal Vasculature
精氨酸摄取机制调节肾脉管系统中的一氧化氮
- 批准号:
7671452 - 财政年份:2003
- 资助金额:
$ 32.02万 - 项目类别:
Arginine Uptake Mechanisms Regulate Nitric Oxide in the Renal Vasculature
精氨酸摄取机制调节肾脉管系统中的一氧化氮
- 批准号:
8136966 - 财政年份:2003
- 资助金额:
$ 32.02万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 32.02万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 32.02万 - 项目类别:
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 32.02万 - 项目类别:
Operating Grants
Antitumor effect of HCC and exosome microRNA by angiotensin II receptor blockers and molecular target drugs
血管紧张素II受体阻滞剂和分子靶向药物对HCC和外泌体microRNA的抗肿瘤作用
- 批准号:
19K17401 - 财政年份:2019
- 资助金额:
$ 32.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects
血管紧张素 II 受体阻滞剂对内皮功能的多效性激活对其保护性抗血管重塑作用至关重要
- 批准号:
411570 - 财政年份:2019
- 资助金额:
$ 32.02万 - 项目类别:
Heterogeneity of Angiotensin II Receptor Blockers in the inhibition of Marfan-associated Aortic Root Dilation Independent of Blood Pressure Effects
血管紧张素 II 受体阻滞剂抑制马凡相关主动脉根部扩张的异质性,与血压影响无关
- 批准号:
391615 - 财政年份:2018
- 资助金额:
$ 32.02万 - 项目类别:
Relationship between serum EETs concentrations and cardiovascular events in patients taking angiotensin II receptor blockers
服用血管紧张素II受体阻滞剂的患者血清EETs浓度与心血管事件的关系
- 批准号:
26460229 - 财政年份:2014
- 资助金额:
$ 32.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The development of new angiotensin II receptor vaccine
新型血管紧张素II受体疫苗的研制
- 批准号:
25870715 - 财政年份:2013
- 资助金额:
$ 32.02万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Central GRK5 modulation of Angiotensin II receptor expression in heart failure
GRK5 对心力衰竭中血管紧张素 II 受体表达的中枢调节
- 批准号:
8531707 - 财政年份:2012
- 资助金额:
$ 32.02万 - 项目类别:
Central GRK5 modulation of Angiotensin II receptor expression in heart failure
GRK5 对心力衰竭中血管紧张素 II 受体表达的中枢调节
- 批准号:
8397394 - 财政年份:2012
- 资助金额:
$ 32.02万 - 项目类别:














{{item.name}}会员




